Roche initiates Phase 1 clinical trial of investigational drug for Down syndrome
Links shared publicly online about this topic.
- 4total visits
Roche initiates Phase 1 clinical trial of investigational drug for Down syndrome
Roche today announced the initiation of its first Phase 1 clinical trial to investigate the safety and tolerability of a molecule designed to address the cognitive and behavioral deficits associated with Down syndrome.
View full resource at news-medical.net
Tags: Genetic, Down Syndrome, Drug, Phase 1 Clinical Trial, Clinical Trial, Oncology, News
Most Recently Shared on September 12, 2011 at 9:09 am By:
Oncology News: Roche initiates Phase 1 clinical trial of investigational drug for Down syndrome: Roche today ann... http://t.co/IZ3yNWX
Advertisement
